John G Ullman & Associates Inc. Cuts Position in GE HealthCare Technologies Inc. $GEHC

John G Ullman & Associates Inc. lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.8% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 51,787 shares of the company’s stock after selling 2,607 shares during the period. John G Ullman & Associates Inc.’s holdings in GE HealthCare Technologies were worth $3,836,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. JPMorgan Chase & Co. lifted its stake in GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the last quarter. Nuveen LLC purchased a new position in GE HealthCare Technologies in the first quarter valued at approximately $77,058,000. Eminence Capital LP lifted its stake in GE HealthCare Technologies by 38.7% in the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after purchasing an additional 507,101 shares during the last quarter. Homestead Advisers Corp lifted its stake in GE HealthCare Technologies by 92.7% in the first quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after purchasing an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board lifted its stake in GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after purchasing an additional 409,636 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research note on Thursday, September 18th. Barclays assumed coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. Finally, Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $85.20.

GE HealthCare Technologies Trading Up 0.9%

Shares of GEHC stock opened at $74.05 on Friday. The company’s fifty day simple moving average is $74.51 and its two-hundred day simple moving average is $72.03. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The stock has a market capitalization of $33.81 billion, a price-to-earnings ratio of 15.17, a PEG ratio of 2.83 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter in the previous year, the firm posted $1.00 EPS. The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.